Bank of America
WINT

Bank of America’s Windtree Therapeutics WINT Stock Holding History

Bank of America’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-103
Closed -$53 – 8719
2025
Q2 		$53 Buy
103
+3
+3% +$3 ﹤0.01% 8089
2025
Q1 		$126 Buy
100
+99
+9,900% +$610 ﹤0.01% 7788
2024
Q4 		$24 Buy
+1
New +$32 ﹤0.01% 7999
2024
Q3 		– Hold
0
– – – 8047
2024
Q2 		– Hold
0
– – – 8063
2021
Q2 		– Hold
0
– – – 8119
2021
Q1 		– Hold
0
– – – 7824

Bank of America's WINT Position: Q3 2025 in Review

Bank of America sold out of Windtree Therapeutics (WINT) in Q3 2025, closing a stake of 103 shares — an estimated $53 sold.

Bank of America first reported a position in WINT in Q4 2024 and held it in 3 quarters. The position peaked at $126 in Q1 2025. 0 funds tracked by Wall St. Rank hold WINT as of Q3 2025.

  • Bank of America reported no remaining Windtree Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 103 Windtree Therapeutics shares in Q3 2025, an estimated $53.
  • Bank of America first reported a position in Windtree Therapeutics in Q4 2024 and held it in 3 quarters.
  • Bank of America's Windtree Therapeutics position peaked at $126 in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.